Angelo Vacca

Q: What Schools Are Affiliated With Angelo Vacca

Angelo Vacca is affiliated with the following schools: University of California, Berkeley, University of Salento, University of Bari, Stanford University, University of Padua, University of Ferrara

Angelo Vacca's AcademicInfluence.com Rankings

Angelo Vacca

Computer Science

#5663

World Rank

#5981

Historical Rank

Computational Linguistics

#846

World Rank

#859

Historical Rank

Machine Learning

#1586

World Rank

#1608

Historical Rank

Artificial Intelligence

#1820

World Rank

#1852

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Angelo Vacca's Degrees

Masters Artificial Intelligence Stanford University
Bachelors Computer Science University of California, Berkeley

Similar Degrees You Can Earn

Why Is Angelo Vacca Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Angelo Vacca's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Bone marrow angiogenesis and progression in multiple myeloma (1994) (676)
Bone marrow neovascularization, plasma cell angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma. (1999) (649)
MHC class I antigen processing and presenting machinery: organization, function, and defects in tumor cells. (2013) (389)
Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. (1999) (383)
Macrophages in rheumatoid arthritis. (2007) (370)
Expression of MAGE genes in primary and metastatic cutaneous melanoma (1995) (297)
Bortezomib mediates antiangiogenesis in multiple myeloma via direct and indirect effects on endothelial cells. (2006) (291)
Chorioallantoic membrane capillary bed: A useful target for studying angiogenesis and anti‐angiogenesis in vivo (2001) (278)
Human Erythropoietin Induces a Pro-Angiogenic Phenotype in Cultured Endothelial Cells and Stimulates Neovascularization In Vivo (1999) (262)
Bone marrow angiogenesis and mast cell density increase simultaneously with progression of human multiple myeloma (1999) (256)
The gelatin sponge–chorioallantoic membrane assay (2006) (236)
New model for the study of angiogenesis and antiangiogenesis in the chick embryo chorioallantoic membrane: the gelatin sponge/chorioallantoic membrane assay. (1997) (233)
Tumor vascularity and tryptase‐positive mast cells correlate with a poor prognosis in melanoma (2003) (231)
TIMP‐2 over‐expression reduces invasion and angiogenesis and protects B16F10 melanoma cells from apoptosis (1998) (221)
The history of the angiogenic switch concept (2007) (220)
Bcr‐Abl stabilizes β‐catenin in chronic myeloid leukemia through its tyrosine phosphorylation (2007) (218)
The chick embryo chorioallantoic membrane as a model for in vivo research on angiogenesis. (1996) (216)
Stephen Paget and the ‘seed and soil’ theory of metastatic dissemination (2006) (198)
Bone marrow angiogenesis in multiple myeloma (2006) (195)
Endothelial cells in the bone marrow of patients with multiple myeloma. (2003) (185)
Angiogenesis spectrum in the stroma of B‐cell non‐Hodgkin's lymphomas. An immunohistochemical and ultrastructural study (2009) (181)
Multiple myeloma exosomes establish a favourable bone marrow microenvironment with enhanced angiogenesis and immunosuppression (2016) (175)
Antiangiogenesis is produced by nontoxic doses of vinblastine. (1999) (174)
Extra-articular manifestations of rheumatoid arthritis: An update. (2011) (173)
Importance of the bone marrow microenvironment in inducing the angiogenic response in multiple myeloma (2006) (163)
Angiogenesis extent and macrophage density increase simultaneously with pathological progression in B-cell non-Hodgkin's lymphomas (1999) (163)
The role of the vascular phase in solid tumor growth: a historical review. (1999) (160)
Penetration and binding of radiolabeled anti-carcinoembryonic antigen monoclonal antibodies and their antigen binding fragments in human colon multicellular tumor spheroids. (1987) (158)
Angiogenesis and mast cell density with tryptase activity increase simultaneously with pathological progression in B‐cell non‐Hodgkin's lymphomas (2000) (155)
In vivo activation of JAK2/STAT‐3 pathway during angiogenesis induced by GM‐CSF (2002) (152)
Erythropoietin as an angiogenic factor (2003) (152)
The role of mast cells in tumour angiogenesis (2001) (149)
A paracrine loop in the vascular endothelial growth factor pathway triggers tumor angiogenesis and growth in multiple myeloma. (2003) (142)
Safety and efficacy of pomalidomide plus low-dose dexamethasone in STRATUS (MM-010): a phase 3b study in refractory multiple myeloma. (2016) (138)
A new image analysis method based on topological and fractal parameters to evaluate the angiostatic activity of docetaxel by using the Matrigel assay in vitro. (2004) (138)
Bone marrow of patients with active multiple myeloma: Angiogenesis and plasma cell adhesion molecules LFA‐1, VLA‐4, LAM‐1, and CD44 (1995) (137)
Docetaxel versus paclitaxel for antiangiogenesis. (2002) (136)
Thalidomide downregulates angiogenic genes in bone marrow endothelial cells of patients with active multiple myeloma. (2005) (133)
Microenvironment drug resistance in multiple myeloma: emerging new players (2016) (133)
Vasculogenic mimicry by bone marrow macrophages in patients with multiple myeloma (2008) (133)
Evaluation of microvascular density in tumors: pro and contra. (2008) (131)
Endothelial cell heterogeneity and organ specificity. (2002) (128)
Salvage therapy with thalidomide in patients with advanced relapsed/refractory multiple myeloma. (2002) (127)
Prognostic value of enhanced bone marrow angiogenesis in early B-cell chronic lymphocytic leukemia. (2002) (125)
Mast cell contribution to angiogenesis related to tumour progression (2004) (124)
Antiangiogenesis Is Produced by Nontoxic Doses of Vinblastine (1999) (123)
The chick embryo chorioallantoic membrane as a model for in vivo research on anti-angiogenesis. (2000) (122)
Neovascularisation, expression of fibroblast growth factor-2, and mast cells with tryptase activity increase simultaneously with pathological progression in human malignant melanoma. (2003) (122)
Inhibition of endothelial cell functions and of angiogenesis by the metastasis inhibitor NAMI-A (2002) (120)
Basic fibroblast growth factor overexpression in endothelial cells: an autocrine mechanism for angiogenesis and angioproliferative diseases. (1996) (119)
Microvessel overexpression of aquaporin 1 parallels bone marrow angiogenesis in patients with active multiple myeloma (2001) (113)
Angiogenesis in B cell lymphoproliferative diseases. Biological and clinical studies. (1995) (108)
Lymphatics at the crossroads of angiogenesis and lymphangiogenesis (2004) (105)
The discovery of angiogenic factors: a historical review. (2000) (104)
Neutrophil Extracellular Traps (NETs) and Damage-Associated Molecular Patterns (DAMPs): Two Potential Targets for COVID-19 Treatment (2020) (103)
The ImmunoCAP ISAC molecular allergology approach in adult multi-sensitized Italian patients with respiratory symptoms. (2011) (103)
Melanocyte tumor progression is associated with changes in angiogenesis and expression of the 67‐kilodalton laminin receptor (1993) (103)
Neovascularization and mast cells with tryptase activity increase simultaneously with pathologic progression in human endometrial cancer. (2005) (103)
The structure of the vascular network of tumors. (2007) (103)
Bone marrow endothelial cells in multiple myeloma secrete CXC‐chemokines that mediate interactions with plasma cells (2005) (100)
Role of endothelial progenitor cells in cancer progression. (2014) (100)
Validation of PDGFRbeta and c-Src tyrosine kinases as tumor/vessel targets in patients with multiple myeloma: preclinical efficacy of the novel, orally available inhibitor dasatinib. (2008) (99)
Progression of mycosis fungoides is associated with changes in angiogenesis and expression of the matrix metalloproteinases 2 and 9. (1997) (97)
The role of microenvironment in tumor angiogenesis (2008) (97)
Dasatinib: an anti-tumour agent via Src inhibition. (2011) (96)
TIMP‐2, Over‐expression reduces invasion and angiogenesis and protects B16F10 melanoma cells from apoptosis. Int. J. Cancer 75, 246–253 (1998) (1999) (96)
Human lymphoblastoid cells produce extracellular matrix-degrading enzymes and induce endothelial cell proliferation, migration, morphogenesis, and angiogenesis (1998) (96)
Gene Expression Profiling of Bone Marrow Endothelial Cells in Patients with Multiple Myeloma (2009) (96)
Alpha(v)beta(3) integrin engagement enhances cell invasiveness in human multiple myeloma. (2002) (93)
Angiogenesis in rheumatoid arthritis. (2006) (91)
Therapeutic targeting of the mTOR‐signalling pathway in cancer: benefits and limitations (2014) (91)
Bone marrow angiogenesis in patients with active multiple myeloma. (2001) (89)
Loss of inhibitory semaphorin 3A (SEMA3A) autocrine loops in bone marrow endothelial cells of patients with multiple myeloma. (2006) (88)
αvβ3 integrin engagement modulates cell adhesion, proliferation, and protease secretion in human lymphoid tumor cells (2001) (85)
Bortezomib as an antitumor agent. (2006) (85)
Bone marrow fibroblasts parallel multiple myeloma progression in patients and mice: in vitro and in vivo studies (2014) (85)
Mast cells and their secretory granules are angiogenic in the chick embryo chorioallantoic membrane (2001) (84)
The discovery of basic fibroblast growth factor/fibroblast growth factor-2 and its role in haematological malignancies. (2007) (83)
Postnatal vasculogenesis (2001) (83)
Angiogenesis and anti-angiogenesis in hepatocellular carcinoma. (2006) (82)
Setting the stage: an anatomist's view of the immune system. (2004) (82)
Vascular endothelial growth factor and its receptors in multiple myeloma (2003) (79)
Do mast cells help to induce angiogenesis in B-cell non-Hodgkin's lymphomas? (1998) (79)
Radioimmunotherapy of human colon carcinoma by 131I‐labelled monoclonal anti‐cea antibodies in a nude mouse model (1988) (78)
Zoledronic acid affects over-angiogenic phenotype of endothelial cells in patients with multiple myeloma (2007) (77)
Hemodynamic Stress, Inflammation, and Intracranial Aneurysm Development and Rupture: A Systematic Review. (2018) (77)
Angiogenesis in asthma (2009) (76)
Crosstalk between angiogenesis and lymphangiogenesis in tumor progression (2004) (76)
Correlation of bone marrow angiogenesis and mast cells with tryptase activity in myelodysplastic syndromes (2002) (75)
Ghrelin inhibits FGF-2-mediated angiogenesis in vitro and in vivo (2004) (75)
Lenalidomide Restrains Motility and Overangiogenic Potential of Bone Marrow Endothelial Cells in Patients with Active Multiple Myeloma (2011) (75)
Cell-Mediated Delivery of Fibroblast Growth Factor-2 and Vascular Endothelial Growth Factor onto the Chick Chorioallantoic Membrane: Endothelial Fenestration and Angiogenesis (2001) (73)
Dendritic cells accumulate in the bone marrow of myeloma patients where they protect tumor plasma cells from CD8+ T-cell killing. (2015) (73)
The role of adrenomedullin in angiogenesis (2005) (72)
Bcl‐2 overexpression in melanoma cells increases tumor progression‐associated properties and in vivo tumor growth (2005) (72)
The additional values of microarray allergen assay in the management of polysensitized patients with respiratory allergy (2013) (71)
In vivo angiogenic activity of urokinase: role of endogenous fibroblast growth factor-2. (1999) (70)
Salvage treatment with lenalidomide and dexamethasone in relapsed/refractory mantle cell lymphoma: clinical results and effects on microenvironment and neo-angiogenic biomarkers (2012) (70)
The role of angiogenesis in human non-Hodgkin lymphomas. (2013) (70)
Tryptase-positive mast cells correlate positively with bone marrow angiogenesis in B-cell chronic lymphocytic leukemia (2003) (70)
Bone marrow fibroblasts overexpress miR‐27b and miR‐214 in step with multiple myeloma progression, dependent on tumour cell‐derived exosomes (2019) (68)
Cancer Associated Fibroblasts and Tumor Growth: Focus on Multiple Myeloma (2014) (68)
Resveratrol Exerts Antiproliferative Activity and Induces Apoptosis in Waldenström's Macroglobulinemia (2008) (68)
Bortezomib in the treatment of cancer. (2006) (68)
Angiogenesis extent and expression of matrix metalloproteinase-2 and -9 correlate with progression in human neuroblastoma. (2001) (68)
Bortezomib and zoledronic acid on angiogenic and vasculogenic activities of bone marrow macrophages in patients with multiple myeloma. (2010) (67)
New non-angiogenesis dependent pathways for tumour growth. (2003) (66)
Mast cells contribute to vasculogenic mimicry in multiple myeloma. (2008) (65)
Metronomic chemotherapy from rationale to clinical studies: a dream or reality? (2015) (65)
Expression on human thymocytes of the idiotypic structures (Ti) from two leukemia T cell lines Jurkat and HPB‐ALL (1986) (64)
Cancer-related coagulopathy (Trousseau’s syndrome): review of the literature and experience of a single center of internal medicine (2013) (63)
A VEGF-dependent autocrine loop mediates proliferation and capillarogenesis in bone marrow endothelial cells of patients with multiple myeloma (2004) (62)
Angiogenesis extent and expression of matrix metalloproteinase‐2 and ‐9 agree with progression of ovarian endometriomas (2002) (62)
Cancer-Associated Angiogenesis: The Endothelial Cell as a Checkpoint for Immunological Patrolling (2020) (61)
Halting pro-survival autophagy by TGFβ inhibition in bone marrow fibroblasts overcomes bortezomib resistance in multiple myeloma patients (2016) (61)
Pemphigus and mucous membrane pemphigoid: An update from diagnosis to therapy. (2019) (60)
Correlation between Serum Tryptase, Mast Cells Positive to Tryptase and Microvascular Density in Colo-Rectal Cancer Patients: Possible Biological-Clinical Significance (2014) (60)
Novel Targeting of Phospho-cMET Overcomes Drug Resistance and Induces Antitumor Activity in Multiple Myeloma (2013) (60)
Leptin–leptin receptor are involved in angiogenesis in human hepatocellular carcinoma (2008) (60)
Erythropoietin/erythropoietin-receptor system is involved in angiogenesis in human hepatocellular carcinoma (2007) (59)
Erythropoietin as an angiogenic factor in gastric carcinoma (2003) (59)
A HGF/cMET Autocrine Loop Is Operative in Multiple Myeloma Bone Marrow Endothelial Cells and May Represent a Novel Therapeutic Target (2014) (59)
Angiogenesis under normal and pathological conditions. (1991) (58)
Macrophages and tumor angiogenesis (2007) (58)
Angiogenesis and mast cells in human breast cancer sentinel lymph nodes with and without micrometastases (2007) (58)
Human neuroblastoma cells produce extracellular matrix‐degrading enzymes, induce endothelial cell proliferation and are angiogenic in vivo (1998) (58)
CXCR3-binding chemokines in multiple myeloma. (2004) (58)
Double‐blind, placebo‐controlled study of sublingual immunotherapy in patients with latex‐induced urticaria: a 12‐month study (2007) (57)
Insights into the Regulation of Tumor Angiogenesis by Micro-RNAs (2019) (57)
18F-FDG PET/CT: a review of diagnostic and prognostic features in multiple myeloma and related disorders (2015) (56)
Synergistic inhibition of human neuroblastoma-related angiogenesis by vinblastine and rapamycin (2005) (56)
JAM-A as a prognostic factor and new therapeutic target in multiple myeloma (2016) (56)
A Mini-Review on Thalidomide: Chemistry, Mechanisms of Action, Therapeutic Potential and Anti-Angiogenic Properties in Multiple Myeloma. (2017) (55)
Levocetirizine in the treatment of chronic idiopathic urticaria: a randomized, double‐blind, placebo‐controlled study (2006) (55)
Therapeutic renaissance of thalidomide in the treatment of haematological malignancies (2005) (55)
Models for Studying Angiogenesis in Vivo (1999) (54)
Subcutaneous immunoglobulins in patients with multiple myeloma and secondary hypogammaglobulinemia: a randomized trial. (2017) (53)
Evidence for Bone Marrow Adult Stem Cell Plasticity: Properties, Molecular Mechanisms, Negative Aspects, and Clinical Applications of Hematopoietic and Mesenchymal Stem Cells Transdifferentiation (2013) (53)
Increased serum levels of matrix metalloproteinase‐9 predict clinical outcome of patients with early B‐cell chronic lymphocytic leukaemia (2003) (52)
HIF-1α of Bone Marrow Endothelial Cells Implies Relapse and Drug Resistance in Patients with Multiple Myeloma and May Act as a Therapeutic Target (2013) (52)
The human melanoma associated protein melanotransferrin promotes endothelial cell migration and angiogenesis in vivo. (2002) (52)
Hypersensitivity to tranexamic acid: a wide spectrum of adverse reactions (2010) (52)
In vivo angiogenic activity of neuroblastoma correlates with MYCN oncogene overexpression (2002) (52)
Microvascular density, vascular endothelial growth factor immunoreactivity in tumor cells, vessel diameter and intussusceptive microvascular growth in primary melanoma. (2005) (52)
Multiple Myeloma Treatment in Real‐world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study (2018) (51)
Vinblastine inhibits the angiogenic response induced by adrenomedullin in vitro and in vivo (2003) (51)
Antiangiogenesis by cyclosporine. (1998) (51)
Recombinant human erythropoietin induces intussusceptive microvascular growth in vivo (2004) (51)
Chlorhexidine Hypersensitivity: A Critical and Updated Review (2013) (50)
High-Risk Multiple Myeloma: Integrated Clinical and Omics Approach Dissects the Neoplastic Clone and the Tumor Microenvironment (2019) (49)
Intussusceptive microvascular growth in human glioma (2010) (49)
Mechanisms of Resistance to Anti-CD38 Daratumumab in Multiple Myeloma (2020) (49)
COVID-19 and the Endocrine System: A Comprehensive Review on the Theme (2021) (49)
Long term follow-up of 168 patients with X-linked agammaglobulinemia reveals increased morbidity and mortality. (2020) (49)
Managing myelodysplastic symptoms in elderly patients (2009) (49)
Bone marrow endothelial cells sustain a tumor-specific CD8+ T cell subset with suppressive function in myeloma patients (2018) (48)
Angiogenesis and anti-angiogenesis in neuroblastoma. (2002) (48)
Multiple Myeloma Macrophages: Pivotal Players in the Tumor Microenvironment (2013) (48)
Angiogenic activity of leptin in the chick embryo chorioallantoic membrane is in part mediated by endogenous fibroblast growth factor-2. (2001) (48)
Endothelial Differentiation of Hematopoietic Stem and Progenitor Cells from Patients with Multiple Myeloma (2008) (47)
Autophagy: A New Mechanism of Prosurvival and Drug Resistance in Multiple Myeloma (2018) (47)
Direct-acting antiviral agents in the therapy of hepatitis C virus-related mixed cryoglobulinaemia: a single-centre experience (2017) (47)
Targeting B-cell non Hodgkin lymphoma: New and old tricks. (2016) (47)
Clinical outcome, incidence, and SARS-CoV-2 infection-fatality rates in Italian patients with inborn errors of immunity (2021) (46)
Inhibition of mTOR complex 2 restrains tumor angiogenesis in multiple myeloma (2018) (46)
Mast cells in rheumatoid arthritis (2006) (45)
Targeting vasculogenesis to prevent progression in multiple myeloma (2016) (45)
TNP‐470 and recombinant human interferon‐α2a inhibit angiogenesis synergistically (2000) (45)
Cancer associated fibroblasts in hematological malignancies (2014) (44)
Actors on the Scene: Immune Cells in the Myeloma Niche (2020) (44)
Angiogenesis and Progression in Human Melanoma (2010) (44)
Soluble Intercellular Adhesion Molecule 1 and Soluble Vascular Cell Adhesion Molecule 1 in Sudden Hearing Loss (2008) (43)
Microenvironment and multiple myeloma spread. (2014) (43)
Anti-angiogenesis and Immunotherapy: Novel Paradigms to Envision Tailored Approaches in Renal Cell-Carcinoma (2020) (43)
Desloratadine in combination with montelukast suppresses the dermographometer challenge test papule, and is effective in the treatment of delayed pressure urticaria: a randomized, double‐blind, placebo‐controlled study (2006) (42)
Tryptase‐positive mast cells predict clinical outcome of patients with early B‐cell chronic lymphocytic leukemia (2003) (42)
Angiogenesis induced by B-cell non-Hodgkin's lymphomas. Lack of correlation with tumor malignancy and immunologic phenotype. (1990) (42)
Antiangiogenesis for rheumatoid arthritis. (2005) (42)
Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real‐Life Setting (2020) (42)
New Insights in Anti-Angiogenesis in Multiple Myeloma (2018) (41)
Hemilipin, a novel Hemiscorpius lepturus venom heterodimeric phospholipase A2, which inhibits angiogenesis in vitro and in vivo. (2015) (41)
Angiogenesis in acute and chronic lymphocytic leukemia. (2004) (40)
Angiogenesis in a human neuroblastoma xenograft model: mechanisms and inhibition by tumour-derived interferon-γ (2006) (40)
Vascular endothelial growth factor and tryptase changes after chemoembolization in hepatocarcinoma patients. (2015) (40)
Thalidomide: a new anticancer drug? (2003) (39)
Halting the vicious cycle within the multiple myeloma ecosystem: blocking JAM-A on bone marrow endothelial cells restores angiogenic homeostasis and suppresses tumor progression (2020) (39)
Hematopoietic cancer and angiogenesis. (2004) (39)
B-cell non-Hodgkin's lymphomas express heterogeneous patterns of neovascularization. (2003) (39)
Cross-talk between hematopoiesis and angiogenesis signaling pathways. (2002) (39)
Alterations of blood vessel development by endothelial cells overexpressing fibroblast growth factor‐2 (1999) (39)
Four proteins governing overangiogenic endothelial cell phenotype in patients with multiple myeloma are plausible therapeutic targets (2012) (38)
Inhibition of neuroblastoma-induced angiogenesis by fenretinide. (2001) (38)
The contribution of Bruce Glick to the definition of the role played by the bursa of Fabricius in the development of the B cell lineage (2006) (38)
Order and disorder in the vascular network (2004) (37)
Targeting angiogenesis in multiple myeloma by the VEGF and HGF blocking DARPin® protein MP0250: a preclinical study (2018) (37)
Angiogenesis in Neuroblastoma (2004) (37)
alpha(v)beta(3) integrin engagement modulates cell adhesion, proliferation, and protease secretion in human lymphoid tumor cells. (2001) (37)
Bone Marrow Angiogenesis and Plasma Cell Angiogenic and Invasive Potential in Patients with Active Multiple Myeloma (2002) (37)
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study (2021) (36)
Proteolytic Activity of Human Lymphoid Tumor Cells. Correlation with Tumor Progression (2000) (36)
Initial presenting manifestations in 16,486 patients with Inborn Errors of Immunity include infections and non-infectious manifestations. (2021) (35)
Expression of tenascin is related to histologic malignancy and angiogenesis in b-cell non-Hodgkin's lymphomas. (1996) (35)
A disturbance of the IL-2/IL-2 receptor system parallels the activity of multiple myeloma. (1991) (35)
Common Variable Immunodeficiency and Gastric Malignancies (2018) (35)
Different Adaptive Responses to Hypoxia in Normal and Multiple Myeloma Endothelial Cells (2018) (34)
Erythropoietin/erythropoietin receptor system is involved in angiogenesis in human neuroblastoma (2007) (34)
The chick embryo chorioallantoic membrane as an in vivo wound healing model. (1996) (33)
Pentraxin 3 (PTX3) inhibits plasma cell/stromal cell cross‐talk in the bone marrow of multiple myeloma patients (2013) (33)
Latex immunotherapy: state of the art. (2012) (33)
Neridronate inhibits angiogenesis in vitro and in vivo (2007) (33)
MicroRNAs-Based Nano-Strategies as New Therapeutic Approach in Multiple Myeloma to Overcome Disease Progression and Drug Resistance (2020) (32)
Novel agents and new therapeutic approaches for treatment of multiple myeloma. (2014) (32)
Role of basic fibroblast growth factor in the formation of the capillary plexus in the chick embryo chorioallantoic membrane. An in situ hybridization, immunohistochemical and ultrastructural study. (1998) (32)
Angiogenesis in vasculitides. (2008) (32)
Clinical practice: hepatitis C virus infection, cryoglobulinemia and cryoglobulinemic vasculitis (2018) (31)
Clodronate inhibits angiogenesis in vitro and in vivo. (2008) (31)
The role of monocytes-macrophages in vasculogenesis in multiple myeloma (2009) (31)
Novel strategies in the treatment of castration-resistant prostate cancer (Review). (2012) (31)
Autoimmune uveitis: a retrospective analysis of 104 patients from a tertiary reference center (2014) (31)
Endogenous and exogenous fibroblast growth factor-2 modulate wound healing in the chick embryo chorioallantoic membrane (2004) (30)
Hematopoiesis and angiogenesis: a link between two apparently independent processes. (2000) (30)
Modifications of the mouse bone marrow microenvironment favor angiogenesis and correlate with disease progression from asymptomatic to symptomatic multiple myeloma (2015) (30)
In vivo time‐course of the angiogenic response induced by multiple myeloma plasma cells in the chick embryo chorioallantoic membrane (2003) (30)
Melphalan versus melphalan plus busulphan in conditioning to autologous stem cell transplantation for low-risk multiple myeloma. (2004) (29)
New Insights into Diffuse Large B-Cell Lymphoma Pathobiology (2020) (29)
Markers of increased angiogenesis and their correlation with biological parameters identifying high-risk patients in early B-cell chronic lymphocytic leukemia. (2007) (29)
Serum angiogenin is not elevated in patients with early B‐cell chronic lymphocytic leukemia but is prognostic factor for disease progression (2004) (29)
Angiogenic activity of multiple myeloma endothelial cells in vivo in the chick embryo chorioallantoic membrane assay is associated to a down-regulation in the expression of endogenous endostatin (2008) (29)
Macrophages in multiple myeloma. (2014) (29)
Multiple myeloma as a model for the role of bone marrow niches in the control of angiogenesis. (2015) (29)
Inhibition of neuroblastoma‐induced angiogenesis by fenretinide (2001) (29)
Miller’s seminal studies on the role of thymus in immunity (2006) (29)
The role of SIRT6 in tumors (2018) (29)
Tumor endothelial markers as a target in cancer (2012) (28)
Vascular endothelial growth factor and vascular endothelial growth factor receptor-2 expression in mdx mouse brain (2002) (28)
Homotypic and Heterotypic Activation of the Notch Pathway in Multiple Myeloma–Enhanced Angiogenesis: A Novel Therapeutic Target?1 (2018) (28)
Immunochemical characterization of two antigens recognized by new monoclonal antibodies against human colon carcinoma. (1986) (28)
Immune Checkpoint Inhibitor-Related Myositis: From Biology to Bedside (2020) (28)
Bortezomib Treatment Modulates Autophagy in Multiple Myeloma (2020) (28)
Endothelial progenitor cells in health and disease. (2005) (28)
Angiogenesis and vasculogenesis in multiple myeloma: role of inflammatory cells. (2011) (28)
Long-term therapy with recombinant human erythropoietin (rHu-EPO) in progressing multiple myeloma (1995) (28)
Angiogenesis during tumor progression in human malignant melanoma. (1992) (27)
Filgrastim, lenograstim and pegfilgrastim in the mobilization of peripheral blood progenitor cells in patients with lymphoproliferative malignancies (2014) (27)
Comparison between filgrastim and lenograstim plus chemotherapy for mobilization of PBPCs (2010) (27)
The small subunit of Hemilipin2, a new heterodimeric phospholipase A2 from Hemiscorpius lepturus scorpion venom, mediates the antiangiogenic effect of the whole protein (2017) (26)
Short-term tolerability of etoricoxib in patients with cutaneous hypersensitivity reactions to nonsteroidal anti-inflammatory drugs. (2005) (26)
Acquired C1‐inhibitor deficiency in a patient with systemic lupus erythematosus: a case report and review of the literature (2005) (26)
Antibody Vh Repertoire Differences between Resolving and Chronically Evolving Hepatitis C Virus Infections (2011) (26)
Functional and Biological Role of Endothelial Precursor Cells in Tumour Progression: A New Potential Therapeutic Target in Haematological Malignancies (2015) (26)
Fenretinide as an anti-angiogenic agent in neuroblastoma. (2003) (25)
Early echocardiographic detection of left ventricular diastolic dysfunction in patients with systemic lupus erythematosus asymptomatic for cardiovascular disease (2019) (25)
Angiogenesis in lipoma: An experimental study in the chick embryo chorioallantoic membrane. (1999) (25)
Angiogenesis in multiple myeloma. (2014) (25)
Prognostic or predictive value of circulating cytokines and angiogenic factors for initial treatment of multiple myeloma in the GIMEMA MM0305 randomized controlled trial (2019) (24)
Skeletal Metastases of Unknown Primary: Biological Landscape and Clinical Overview (2019) (24)
Human recombinant interferon alpha-2a inhibits angiogenesis of chick area vasculosa in shell-less culture. (1996) (24)
Novel therapeutic approaches targeting vascular endothelial growth factor and its receptors in haematological malignancies. (2005) (24)
Increased matrix-metalloproteinase-2 and matrix-metalloproteinase-9 expression in the brain of dystrophic mdx mouse (2006) (23)
Anti-angiogenic activity of the purine analog 6-thioguanine (2002) (23)
Shift from intravenous or 16% subcutaneous replacement therapy to 20% subcutaneous immunoglobulin in patients with primary antibody deficiencies (2016) (23)
Endothelial progenitor cells in sudden sensorineural hearing loss (2011) (22)
In vivo inhibition of human hepatocellular carcinoma related angiogenesis by vinblastine and rapamycin. (2007) (22)
Bone Marrow Stromal Cells-Induced Drug Resistance in Multiple Myeloma (2020) (22)
Severe pulmonary hypertension as the initial manifestation of systemic lupus erythematosus: a case report and review of the literature. (2014) (22)
Retinoids: novel immunomodulators and tumour‐suppressive agents? (2012) (21)
Human chorionic gonadotropin inhibits Kaposi's sarcoma associated angiogenesis, matrix metalloprotease activity, and tumor growth. (2002) (21)
Cancer treatment and the KIR–HLA system: an overview (2017) (21)
Serum levels of angiogenic cytokines decrease after radiotherapy in non-Hodgkin lymphomas (2008) (21)
Effect of Low-Density Lipoprotein Apheresis on Circulating Endothelial Progenitor Cells in Familial Hypercholesterolemia (2010) (21)
[Angiogenesis and tumor progression in melanoma]. (2000) (21)
Considerations in the treatment of multiple myeloma: a consensus statement from Italian experts (2009) (21)
Erythropoietin is involved in the angiogenic potential of bone marrow macrophages in multiple myeloma (2013) (20)
Ocular Involvement in Systemic Lupus Erythematosus: The Experience of Two Tertiary Referral Centers (2018) (20)
Mast Cell Heterogeneity in B-cell Non-Hodgkin's Lymphomas: An Ultrastructural Study (2002) (20)
HB-EGF–EGFR Signaling in Bone Marrow Endothelial Cells Mediates Angiogenesis Associated with Multiple Myeloma (2020) (20)
Tumoral mast cells exhibit a common spatial distribution. (2009) (20)
NK cells and multiple myeloma-associated endothelial cells: molecular interactions and influence of IL-27 (2017) (20)
Serum levels of angiogenic cytokines decrease after antineoplastic radiotherapy. (2004) (20)
Amyloidosis and Ocular Involvement: an Overview (2019) (20)
Survivin overexpression in head and neck squamous cell carcinomas as a new therapeutic target (Review). (2019) (19)
An alternative in vivo system for testing angiogenic potential of human neuroblastoma cells. (2009) (19)
Tryptase serum levels in patients suffering from hepatocellular carcinoma undergoing intra-arterial chemoembolization: Possible predictive role of response to treatment. (2013) (19)
High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with high-risk Hodgkin’s lymphoma (2012) (19)
Temporal expression of the matrix metalloproteinase MMP‐2 correlates with fibronectin immunoreactivity during the development of the vascular system in the chick embryo chorioallantoic membrane (1999) (19)
Epha3 acts as proangiogenic factor in multiple myeloma (2017) (19)
Chronic inflammation enhances NGF-β/TrkA system expression via EGFR/MEK/ERK pathway activation in Sjögren’s syndrome (2014) (19)
Treatment of multiple myeloma: a randomized study of three different regimens. (1985) (18)
Mast Cells and Angiogenesis in Human Plasma Cell Malignancies (2019) (18)
Orbital pseudotumor in a child: diagnostic implications and treatment strategies (2011) (18)
Once daily levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria (2008) (18)
Cyclosporin-A Efficacy in Chronic Idiopathic Urticaria (2011) (18)
Ultrastructural Analysis of Mast Cell Recovery after Secretion by Piecemeal Degranulation in B-cell Non-Hodgkin's Lymphoma (2003) (18)
A retrospective study of skeletal and disease-free survival benefits of zoledronic acid therapy in patients with multiple myeloma treated with novel agents. (2013) (18)
Angiogenesis, angiogenic factor expression and hematological malignancies. (2001) (18)
Polyethylene glycols and polysorbates: Two still neglected ingredients causing true IgE-mediated reactions. (2019) (18)
Anti-VEGF Drugs in the Treatment of Multiple Myeloma Patients (2020) (18)
Localization of factor VIII-related antigen in the endothelium of the chick embryo chorioallantoic membrane (1999) (17)
Angiogenesis in hepatocellular carcinoma: an experimental study in the chick embryo chorioallantoic membrane. (1998) (17)
Short-Term Variations in Neutrophil-to-Lymphocyte and Urea-to-Creatinine Ratios Anticipate Intensive Care Unit Admission of COVID-19 Patients in the Emergency Department (2021) (17)
Second-line treatments for Advanced Hepatocellular Carcinoma: A Systematic Review and Bayesian Network Meta-analysis (2021) (17)
Systemic sclerosis stimulates angiogenesis in the chick embryo chorioallantoic membrane (2005) (17)
Probiotics and refractory chronic spontaneous urticaria. (2016) (17)
Phthalimide Derivative Shows Anti-angiogenic Activity in a 3D Microfluidic Model and No Teratogenicity in Zebrafish Embryos (2019) (17)
Dendritic cell maturation in HCV infection: altered regulation of MHC class I antigen processing-presenting machinery. (2014) (16)
Anti-COVID-19 Vaccination in Patients with Autoimmune-Autoinflammatory Disorders and Primary/Secondary Immunodeficiencies: The Position of the Task Force on Behalf of the Italian Immunological Societies (2021) (16)
Flow cytometric basophil activation test: detection of CD63 expression as a useful aid to diagnosis of latex allergy. (2006) (16)
B16-F10 melanoma cells contribute to the new formation of blood vessels in the chick embryo chorioallantoic membrane through vasculogenic mimicry (2013) (16)
Vascular endothelial growth factor-A, vascular endothelial growth factor receptor-2 and angiopoietin-2 expression in the mouse choroid plexuses (2004) (16)
Role of erythropoietin in the angiogenic activity of bone marrow endothelial cells of MGUS and multiple myeloma patients (2016) (16)
Overview of Angiogenesis During Tumor Growth (2008) (15)
Bone Marrow CX3CL1/Fractalkine is a New Player of the Pro-Angiogenic Microenvironment in Multiple Myeloma Patients (2019) (15)
Angiogenic activity of rat mast cells in the chick embryo chorioallantoic membrane is down-regulated by treatment with recombinant human alpha-2a interferon and partly mediated by fibroblast growth factor-2. (2002) (15)
The Employment of Leukotriene Antagonists in Cutaneous Diseases Belonging to Allergological Field (2010) (15)
Differential expression of two ICAM‐1 epitopes and LFA‐1 chains in B‐cell non‐Hodgkin's lymphomas (1994) (15)
Intense reversal of bone marrow angiogenesis after sequential fludarabine-induction and alemtuzumab-consolidation therapy in advanced chronic lymphocytic leukemia. (2007) (15)
Improving knowledge on the activation of bone marrow fibroblasts in MGUS and MM disease through the automatic extraction of genes via a nonnegative matrix factorization approach on gene expression profiles (2018) (15)
Delayed‐type hypersensitivity to bupivacaine (2007) (15)
Imaging of human leukemic T‐Cell Xenografts in nude mice by radiolabeled monoclonal antibodies and F(ab')2 fragments (1988) (15)
An experimental study in the chick embryo chorioallantoic membrane of the anti-angiogenic activity of cyclosporine in rheumatoid arthritis versus osteoarthritis (2000) (15)
Antibiotics or No Antibiotics, That Is the Question: An Update on Efficient and Effective Use of Antibiotics in Dental Practice (2021) (15)
Rhu-Epo down-regulates pro-tumorigenic activity of cancer-associated fibroblasts in multiple myeloma (2018) (15)
In vivo absence of synergism between fibroblast growth factor-2 and vascular endothelial growth factor. (2001) (14)
High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with high-risk non-Hodgkin lymphoma (2012) (14)
Antiangiogenic therapeutic approaches in multiple myeloma. (2012) (14)
Bone marrow vascular niche and the control of angiogenesis in multiple myeloma. (2014) (14)
Gene expression profiling of normal thyroid tissue from patients with thyroid carcinoma (2016) (14)
Myeloma cells act as tolerogenic antigen‐presenting cells and induce regulatory T cells in vitro (2015) (14)
The role of inflammatory cells in angiogenesis in multiple myeloma. (2014) (14)
Safety of parecoxib in patients with nonsteroidal anti-inflammatory drug-induced urticaria or angioedema. (2008) (14)
Anti-angiogenic activity of carebastine: a plausible mechanism affecting airway remodelling (2009) (14)
Exogenous heparin induces fibronectin overexpression parallel to angiogenesis in the extracellular matrix of the chick embryo chorioallantoic membrane. (1997) (14)
Serum levels of syndecan-1 in B-cell chronic lymphocytic leukemia: Correlation with the extent of angiogenesis and disease-progression risk in early disease (2006) (14)
Pomalidomide + Low-Dose Dexamethasone in Patients with Refractory or Relapsed and Refractory Multiple Myeloma and Renal Impairment: Analysis of Patients from the Phase 3b Stratus Trial (MM-010) (2014) (14)
Contact allergy to benzocaine in a condom (2008) (14)
The safety of a novel sublingual rush induction phase for latex desensitization (2010) (14)
Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor-2 Expression in the Chick Embryo Area Vasculosa (2001) (13)
[Chemokines and tumors]. (2002) (13)
Postoperative pain monitor after total knee replacement (2011) (13)
Stimulation of invariant natural killer T cells by α‐Galactosylceramide activates the JAK‐STAT pathway in endothelial cells and reduces angiogenesis in the 5T33 multiple myeloma model (2014) (13)
A possible role of tryptase in angiogenesis in the brain of mdx mouse, a model of Duchenne muscular dystrophy (2004) (13)
Identify multiple myeloma stem cells: Utopia? (2015) (13)
Acute Intrathoracic Gastric Volvulus from a Diaphragmatic Hernia after Left Splenopancreatectomy: Report of a Case (2006) (13)
The Impact of SARS-CoV-2 Infection in Patients with Inborn Errors of Immunity: the Experience of the Italian Primary Immunodeficiencies Network (IPINet) (2022) (13)
Echocardiographic findings and plasma endothelin-1 levels in obese patients with and without obstructive sleep apnea (2016) (13)
Risk of acute arterial and venous thromboembolic events in eosinophilic granulomatosis with polyangiitis (Churg–Strauss syndrome) (2020) (13)
Role of Extracellular Vesicle-Based Cell-to-Cell Communication in Multiple Myeloma Progression (2021) (13)
Rupatadine for the treatment of urticaria (2013) (12)
Role of Hematopoietic Growth Factors in Angiogenesis (2002) (12)
A Comprehensive Biological and Clinical Perspective Can Drive a Patient-Tailored Approach to Multiple Myeloma: Bridging the Gaps between the Plasma Cell and the Neoplastic Niche (2020) (12)
Molecular diagnosis and the Italian Board for ISAC. (2014) (12)
Pharmacokinetic and metabolism determinants of fluoropyrimidines and oxaliplatin activity in treatment of colorectal patients. (2011) (12)
Inflammation and antiangiogenesis in cancer. (2012) (12)
Belimumab restores Treg/Th17 balance in patients with refractory systemic lupus erythematosus (2018) (12)
Role of Endothelial Cells and Fibroblasts in Multiple Myeloma Angiogenic Switch. (2016) (12)
In situ hybridization and immunogold localization of vascular endothelial growth factor receptor-2 on the pericytes of the chick chorioallantoic membrane. (2002) (12)
Heavy-Chain Diseases and Myeloma-Associated Fanconi Syndrome: an Update (2018) (11)
Serum insulin‐like growth factor is not elevated in patients with early B‐cell chronic lymphocytic leukemia but is still a prognostic factor for disease progression (2006) (11)
Isolation and characterization of neural stem cells from dystrophic mdx mouse. (2016) (11)
Multiple myeloma and mycosis fungoides in the same patient: clinical, immunologic, and molecular studies (2002) (11)
Kounis Syndrome induced by intravenous administration of piperacillin/tazobactam: a case report. (2012) (11)
Monoclonal antibodies against idiotypic determinant(s) of the T cell receptor from HPB‐ALL cells induce IL 2 production in Jurkat cells without apparent evidence of binding (1986) (11)
Translocation of the proto-oncogene Bcl-6 in human glioblastoma multiforme. (2014) (11)
Granulomatous Lymphocytic Interstitial Lung Disease (GLILD) in Common Variable Immunodeficiency (CVID): A Multicenter Retrospective Study of Patients From Italian PID Referral Centers (2021) (10)
Immediate-type hypersensitivity reaction to Mannitol as drug excipient (E421): a case report. (2015) (10)
"Real world" outcome of lenalidomide plus dexamethasone in the setting of recurrent and refractory multiple myeloma: extended follow-up of a retrospective multicenter study by the "rete ematologica pugliese". (2015) (10)
Deflazacort versus Prednisone in the Treatment of Essential Mixed Cryoglobulinemia A Between-Patient Controlled Clinical Study. (1992) (10)
Angiogenesis: basic and clinical aspects. (2003) (10)
Pyogenic granuloma stimulates angiogenesis in the chick embryo chorioallantoic membrane. (1996) (10)
Induction Therapy and Stem Cell Mobilization in Patients with Newly Diagnosed Multiple Myeloma (2012) (10)
Current Take on Systemic Sclerosis Patients’ Vaccination Recommendations (2021) (10)
Giant Cell Arteritis: The Experience of Two Collaborative Referral Centers and an Overview of Disease Pathogenesis and Therapeutic Advancements (2020) (10)
Translational impact of novel widely pharmacological characterized mofezolac-derived COX-1 inhibitors combined with bortezomib on human multiple myeloma cell lines viability. (2019) (10)
Adhesion-Mediated Multiple Myeloma (MM) Disease Progression: Junctional Adhesion Molecule a Enhances Angiogenesis and Multiple Myeloma Dissemination and Predicts Poor Survival (2019) (9)
A multiple myeloma that progressed as type I cryoglobulinemia with skin ulcers and foot necrosis (2018) (9)
Does Adiponectin Act as an Antiangiogenic Factor in B-Cell Chronic Lymphocytic Leukemia? (2009) (9)
Intelligent Microarray Data Analysis through Non-negative Matrix Factorization to Study Human Multiple Myeloma Cell Lines (2019) (9)
The Italian Registry for Primary Immunodeficiencies (Italian Primary Immunodeficiency Network; IPINet): Twenty Years of Experience (1999–2019) (2020) (9)
Salvage Treatment with Lenalidomide and Dexamethasone In Patients with Relapsed Refractory Mantle Cell Lymphoma: Clinical Results and Modifications of Angiogenic Biomarkers (2010) (9)
Artificial Intelligence in Dermatopathology: New Insights and Perspectives (2021) (9)
Late recovery with cyclosporine-A of an auto-immune sudden sensorineural hearing loss (2011) (9)
MicroRNAs as a Potential New Preventive Approach in the Transition from Asymptomatic to Symptomatic Multiple Myeloma Disease (2021) (9)
Treatment of acquired cold urticaria with rupatadine (2009) (9)
Galectin-3 and neutrophil-to-lymphocyte ratio are indicative of heart remodelling and disease severity in patients with obstructive sleep apnoea. (2021) (8)
Loss of bone mineral density and secondary hyperparathyroidism are complications of autologous stem cell transplantation (2007) (8)
Uridine and pyruvate protect T cells’ proliferative capacity from mitochondrial toxic antibiotics: a clinical pilot study (2021) (8)
Aquaporin-4 expression in primary human central nervous system lymphomas correlates with tumour cell proliferation and phenotypic heterogeneity of the vessel wall. (2012) (8)
The Leading Role of the Immune Microenvironment in Multiple Myeloma: A New Target with a Great Prognostic and Clinical Value (2022) (8)
Anti-Angiogenesis Drug Discovery and Development (2018) (8)
Bone marrow angiogenesis and progression in multiple myeloma. (2011) (8)
Takayasu arteritis: a cohort of Italian patients and recent pathogenetic and therapeutic advances (2020) (8)
Involvement of new oxidative stress markers in chronic spontaneous urticaria (2017) (8)
Morphometry and mathematical modelling of the capillary-like patterns formed in vitro by bone marrow macrophages of patients with multiple myeloma (2007) (8)
Pharmacological Activation of Protein Phosphatase 2 A (PP2A): A Novel Strategy to Fight Against Human Malignancies? (2016) (8)
Is the localized seminal plasma hypersensitivity the mucosal aspect of protein contact dermatitis? (2015) (8)
Endothelial cells in the bone marrow of multiple myeloma (2003) (8)
90Y-Ibritumomab Tiuxetan as Consolidation Therapy After Autologous Stem Cell Transplantation in Aggressive Non-Hodgkin Lymphoma (2011) (7)
Long-term selective IgE-mediated hypersensitivity to hydrocortisone sodium succinate. (2013) (7)
The wide spectrum of cryoglobulinemic vasculitis and an overview of therapeutic advancements (2022) (7)
Right Heart Changes Impact on Clinical Phenotype of Amyloid Cardiac Involvement: A Single Centre Study (2020) (7)
Development of vasculature targeting strategies for the treatment of chronic inflammatory diseases. (2005) (7)
Long-Term Tolerability of Etoricoxib in Patients with Previous Reactions to Non-Steroidal Anti-Inflammatory Drugs (2009) (7)
Surgical resection of locally advanced epidermal growth factor receptor (EGFR) mutated lung adenocarcinoma after gefitinib and review of the literature. (2013) (7)
Therapeutic alternatives in a patient with DRESS syndrome induced by allopurinol. (2009) (7)
Endometrial hyperplasia and endometrial carcinoma induce a vasoproliferative response in the chick embryo chorioallantoic membrane. (1996) (7)
Reversal of bone marrow angiogenesis in chronic lymphocytic leukemia following fludarabine therapy. (2005) (7)
Neutropenia and G-CSF in lymphoproliferative diseases (2013) (7)
Antiangiogenesis by chemotherapeutic agents. (2005) (7)
Idiopathic nonhistaminergic angioedema: A single‐center real‐life experience from Italy (2019) (6)
An Italian pioneer in the study of tumor angiogenesis. (2001) (6)
SARS-CoV-2 and Skin: New Insights and Perspectives (2022) (6)
Cyclic lysozyme administration as a tool for immunopotentiation in patients with multiple myeloma. (1985) (6)
Telemedicine DSS-AI Multi Level Platform for Monoclonal Gammopathy Assistance (2020) (6)
Spotlight on Cardiovascular Scoring Systems in Covid-19: Severity Correlations in Real-world Setting (2021) (6)
Systemic Vasculitides: Current Status and Perspectives (2016) (6)
Parecoxib as an Alternative in COX-2 Hypersensitivity (2008) (6)
Suspected Pericardial Tuberculosis Revealed as an Amyloid Pericardial Mass (2018) (6)
Integrated lung ultrasound score for early clinical decision-making in patients with COVID-19: results and implications (2022) (6)
Management of common variable immunodeficiency by subcutaneous IgG self‐administration during pregnancy – a case report (2017) (6)
Effect of thyroidectomy on circulating angiogenic cytokines in papillary thyroid carcinoma and benign goiter: Potential for new biomarkers? (2020) (6)
Prognostic and Therapeutic Role of Angiogenic Microenvironment in Thyroid Cancer (2021) (6)
Multiple Myeloma: The Role of Angiogenesis in Disease Progression (2013) (6)
Efficacy and rapid activity of omalizumab retreatment in chronic spontaneous urticaria (2017) (6)
Multiple Myeloma - a New Era of Treatment Strategies (2012) (5)
Effect of homotaurine in patients with cognitive impairment: Results from an Italian observational retrospective study (2018) (5)
Imaging and angiogenesis in hematological malignancies (2007) (5)
Myeloma cells regulate miRNA transfer from fibroblast‐derived exosomes by expression of lncRNAs (2021) (5)
Safety and ef fi cacy of pomalidomide plus low-dose dexamethasone in STRATUS ( MM-010 ) : a phase 3 b study in refractory multiple myeloma (2016) (5)
Thrombopoietin promotes angiogenesis and disease progression in patients with multiple myeloma. (2021) (5)
Thymidine phosphorylase (platelet-derived endothelial cell growth factor) as a target for capecitabine: from biology to the bedside. (2006) (5)
Angiogenesis and Antiangiogenesis in Multiple Myeloma (2018) (5)
Acquired Angioedema with C1 Inhibitor Deficiency Associated with Anticardiolipin Antibodies (2011) (5)
The Landscape of lncRNAs in Multiple Myeloma: Implications in the “Hallmarks of Cancer”, Clinical Perspectives and Therapeutic Opportunities (2022) (5)
Immunomodulation of T and B cell functions in multiple myeloma patients treated with combined erythropoietin and α-interferon therapy (1995) (5)
Bamlanivimab and Etesevimab administered in an outpatient setting for SARS-CoV-2 infection (2022) (5)
Maculopapular rash due to fluconazole (2009) (5)
Anti-angiogenesis: a multipurpose therapeutic tool? (1993) (5)
Long-Term Follow-Up May be Useful in Coronavirus Disease 2019 Survivors to Prevent Chronic Complications (2020) (5)
Corona Virus Disease 19 (CoViD-19) impact on cardiovascular disease in a non-CoViD-19 emergency setting (2021) (4)
The bone marrow microenvironment in multiple myeloma: Cellular and molecular basis of disease progression (2011) (4)
The Occurrence of Plasma Fibronectin in Mixed Cryoglobulins from Patients with Liver Cirrhosis1 (1984) (4)
Functional interplay between NF-κB-inducing kinase and c-Abl kinases limits response to Aurora inhibitors in multiple myeloma (2019) (4)
Resveratrol Exerts Antiproliferative Effect and Induces Apoptosis in Waldenstrom’s Macroglobulinemia. (2007) (4)
Central Function for JAM-a in Multiple Myeloma Patients with Extramedullary Disease (2018) (4)
The role of dental series patch tests in oral mucosal diseases. (2010) (4)
Dermatopathology of Malignant Melanoma in the Era of Artificial Intelligence: A Single Institutional Experience (2022) (4)
Direct and Indirect Costs of Immunoglobulin Replacement Therapy in Patients with Common Variable Immunodeficiency (CVID) and X-Linked Agammaglobulinemia (XLA) in Italy (2018) (4)
Angiogenesis in Chronic Lymphocytic Leukemia: An Emerging Target (2006) (4)
Short-Term Tolerability of Morniflumate in Patients with Cutaneous Hypersensitivity Reactions to Non-Steroidal Anti-Inflammatory Drugs (2013) (4)
[Angiogenesis and anti-angiogenesis in human neoplasms. Recent developments and the therapeutic prospects]. (2000) (4)
Cross talk between haematopoiesis and angiogenesis. (2003) (4)
Angiogenesis and anti-angiogenesis in haematological diseases (2008) (4)
Identification and monitoring of Copy Number Variants (CNV) in monoclonal gammopathy (2021) (4)
Angiogenesis and thalidomide in plasma cell disorders (2002) (3)
Surgical resection of locally advanced epidermal growth factor receptor (EGFR) mutated lung adenocarcinoma after gefitinib and review of the literature (2013) (3)
Partial response of liver metastases treated with abiraterone in castration-resistant prostate cancer: A case report (2013) (3)
Immediate rhinoconjunctivitis induced by metamizole: an allergic reaction? (2010) (3)
Erratum: TIMP-2, over-expression reduces invasion and angiogenesis and protects B16F10 melanoma cells from apoptosis (International Journal of Cancer (1998) 75 (246-253)) (1999) (3)
Cancer Stem Cells in Multiple Myeloma and the Development of Novel Therapeutic Strategies (2019) (3)
The bone marrow niche landscape: a journey through aging, extrinsic and intrinsic stressors in the haemopoietic milieu (2022) (3)
Extramedullary Plasmacytoma Mimicking Pancreatic Cancer: An Unusual Presentation (2016) (3)
Could multiple myeloma VEGF modify the systemic microcirculation? (2012) (3)
A joint allergist/cardiologist classification for thienopyridines hypersensitivity reactions based on their symptomatic patterns and its impact on the management strategies. (2016) (3)
Adoption of open innovation in the COVID-19 emergency: developing a process-based information coordination system (2022) (3)
Serum Free Light Chains in Common Variable Immunodeficiency Disorders: Role in Differential Diagnosis and Association With Clinical Phenotype (2020) (3)
Analysis of Aortic Remodeling and Stiffness in Patients with Obstructive Sleep Apnea Syndrome: Preliminary Results. (2018) (3)
A Challenging Case of Visceral Leishmaniasis (2022) (3)
The Spectrum of Ocular Manifestations in Patients with Waldenström’s Macroglobulinemia (2021) (3)
A case of Cogan′s syndrome resolved with mycophenolate sodium (2008) (3)
The MP0250-CP201 Mirror Study: A Phase 2 Study Update of MP0250 Plus Bortezomib and Dexamethasone in Relapse/Refractory Multiple Myeloma (RRMM) Patients Previously Exposed to Proteasome Inhibitors and Immunomodulatory Drugs (2019) (3)
VEGF and Tumor Progression in Human Melanoma (2004) (3)
Right atrium enlargement is related to increased heart damage and mortality in well-controlled hypertension. (2021) (3)
ANALYSIS OF PATIENTS WITH REFRACTORY OR RELAPSED AND REFRACTORY MULTIPLE MYELOMA AND RENAL IMPAIRMENT TREATED WITH POMALIDOMIDE plus LOW-DOSE DEXAMETHASONE IN THE PHASE 3B STRATUS TRIAL (MM-010) (2015) (3)
Jejunal overexpression of peptide YY in celiac disease complicated with pneumatosis cystoides intestinalis (2015) (3)
Tomato atopy patch test in adult atopic dermatitis: diagnostic value and comparison among different methods (2009) (2)
Follicular helper T cell signature of replicative exhaustion, apoptosis, and senescence in common variable immunodeficiency (2021) (2)
Angiogenesis extent and expression of matrix metalloproteinase-2 and -9 in ovarian endometriomata. (2001) (2)
Correlative study of angiogenesis in endometrial cancer assessed by the color Doppler ultrasound and by the chick embryo chorioallantoic membrane. (1997) (2)
Diagnosis of Latex Allergy: The Importance of Hev b 11 (2012) (2)
Multiple MyelomaMacrophages : Pivotal Players in the TumorMicroenvironment (2015) (2)
Injured skin as risk factor for chlorhexidine anaphylaxis. (2018) (2)
Outcomes for Older Patients in Stratus (MM-010), a Single-Arm, and Phase 3b Study of Pomalidomide + Low-Dose Dexamethasone in Refractory or Relapsed and Refractory Multiple Myeloma (2014) (2)
Antiangiogenic Treatment of Hematological Tumors (2011) (2)
TOP2A expression predicts responsiveness to carfilzomib in myeloma and informs novel combinatorial strategies for enhanced proteasome inhibitor cell killing (2020) (2)
Recent Advances in Angiogenesis and Antiangiogenesis (2018) (2)
Pathways of Angiogenic and Inflammatory Cytokines in Multiple Myeloma: Role in Plasma Cell Clonal Expansion and Drug Resistance (2022) (2)
Serum free light chains as a possible diagnostic tool in primary hypogammaglobulinemia: a multicentric study on 344 CVID patients (2017) (2)
A favorable response to omalizumab in a patient with cheilitis granulomatosa. (2018) (2)
Immunoglobulin secretion by peripheral blood and bone marrow B cells in patients with multiple myeloma. Studies by the reverse haemolytic plaque assay. (1984) (2)
Inborn Error of Immunity: A Journey Through Novel Genes and Clinical Presentation (2021) (2)
Omalizumab For The Treatment of Persistent Drug Induced Urticaria Elicited By Thienopyridines: A Case Report. (2020) (2)
Coordinate immunoreactivity to vascular endothelial growth factor receptor-2 and its ligand suggests a paracrine regulation during the development of the vascular system in the chick embryo bursa of Fabricius. (2001) (2)
Vascular endothelial growth factor as an effector of mast cell-induced tumor angiogenesis (2005) (2)
Determination of vascularization of B-cell non-Hodgkin's lymphomas with four markers. (1996) (2)
Dasatinib Inhibits Multiple Myeloma Growth by Blocking PDGF-Rb and c-Src Activity in Patient-Derived Tumor and Endothelial Cells. (2007) (2)
[Role of the vascular component in growth of solid tumors: a historical review]. (1994) (2)
Is thalidomide a true anti-angiogenic molecule in multiple myeloma? (2002) (2)
The differential reactivity of cells of the melanocytic lineage with four monoclonal antibodies against IFN-gamma inducible molecules. (1992) (2)
MicroRNAs to know in Waldenstrom macroglobulinemia. (2009) (1)
Vascular Targeting: A New Antitumor Activity (2004) (1)
Should succinate esters be considered excipients in systemic corticosteroid allergy? (2019) (1)
Genetic and epigenetic mechanisms of multiple myeloma (2004) (1)
Stimulation of antibody response in the gastrointestinal mucosa of immunodeficient mice by oral treatment with bacterial antigens. An immunoperoxidase study. (1989) (1)
Delayed complete remission in a patient with multiple myeloma (2008) (1)
On the use of thalidomide as an antiangiogenic agent in the treatment of multiple myeloma (2003) (1)
Hypersensitivity to Vitamins with a Focus on Immediate-Type Reactions: Food or Drug Allergy? (2020) (1)
Corrigendum to "Isolation and characterization of neural stem cells from dystrophic mdx mouse" [Exp. Cell Res. 343(2016)190-207]. (2016) (1)
Chapter 3 – Anti-Angiogenesis in Multiple Myeloma (2017) (1)
Artificial Intelligence in Dermatopathology: a single institutional study (2022) (1)
Allergic Reactions to Inhalant Glucocorticosteroids: A Hot Topic for Pneumologists and Allergologists (2006) (1)
EphA3 As a Molecular Target In Multiple Myeloma: Opportunity For a Novel Therapeutic Approach With a Specific Monoclonal Antibody (2013) (1)
Highlights in clinical medicine—Giant cell arteritis, polymyalgia rheumatica and Takayasu’s arteritis: pathogenic links and therapeutic implications (2021) (1)
The COVID-19 Stress Perceived on Social Distance and Gender-Based Implications (2022) (1)
Hypoxia-Inducible Factor-1 in Multiple Myeloma Progression. (2009) (1)
The Italian Society of Immunology: past, present and future (2010) (1)
Stimulation of residual B-cell immunity in nude mice by pidotimod: an immunohistological study (1993) (1)
Early administration of tofacitinib in COVID‐19 pneumonitis: An open randomised controlled trial (2022) (1)
Cancer Associated Fibroblasts in Multiple Myeloma: The Urokinase Receptor System in Tumor Growth Regulation (2014) (1)
Move Toward to Non Invasive Mechanical Ventilation in Amyotrophic Lateral Sclerosis: A Clinical Review (2018) (1)
Fainting as an unusual presentation of a large inferior vena cava leiomyosarcoma (2015) (1)
Erythropoietin is involved in the angiogenic potential of bone marrow macrophages in multiple myeloma (2013) (1)
Monoclonal gammopathy as a marker of primary cerebral lymphoma (2009) (1)
1041TiPMP0250 – a dual inhibitor of VEGF and HGF - plus bortezomib + dexamethasone in a phase 2 open-label, single-arm, multicenter trial in patients with refractory and relapsed multiple myeloma (RRMM) (2017) (1)
Peripheral Blood Progenitor Cells Mobilization in Patients with Multiple Myeloma (2014) (1)
MP0250 Combined with Bortezomib and Dexamethasone in Multiple Myeloma Patients Previoulsy Exposed to Proteasome Inhibitors and Immunomodulatory Drugs (2018) (1)
Promising Use Of The New Biologics In The Management Of Drug-Induced Hypersensitivity Reactions: Preliminary Approaches. (2020) (1)
Immediate-type hypersensitivity to systemic glucocorticoids: an underrated drug allergy. (2011) (1)
[Critical course of a case of idiopathic pulmonary fibrosis]. (1995) (1)
Allergen Component Resolved Diagnostics in Multi-Sensitized Patients with Respiratory Symptoms (2010) (1)
Role of Angiogenesis and Microenvironment in Melanoma Progression (2011) (1)
Comprehensive Review Angiogenesis and Anti-Angiogenesis in Hematological Malignancies (2003) (1)
Right heart enlargement in well-controlled under treatment hypertensive patients (2017) (0)
Intense Reversal of Bone Marrow Angiogenesis after Consolidation Therapy with Alemtuzumab in Advanced Chronic Lymphocytic Leukemia. (2006) (0)
HBeAg/Anti-HBe circulating immune complexes in patients chronically infected with hepatitis B virus (1989) (0)
Subject Index Vol. 29, 2010 (2010) (0)
An atypical presentation of intestinal neuroendocrine tumor. (2015) (0)
Inhibition of mTOR as Antiangiogenic Strategy in Multiple Myeloma (2015) (0)
marrow endothelial cells of patients with multiple myeloma Loss of inhibitory semaphorin 3A (SEMA3A) autocrine loops in bone (2011) (0)
Angiogenesis, s and Clinical Implications (2015) (0)
circPVT1 and PVT1/AKT3 show a role in cell proliferation, apoptosis, and tumor subtype-definition in Small Cell Lung Cancer. (2022) (0)
Lung Ultrasound Is Useful for Evaluating Lung Damage in COVID-19 Patients Treated with Bamlanivimab and Etesevimab: A Single-Center Pilot Study (2023) (0)
Review Macrophages in rheumatoid arthritis (2007) (0)
Outcomes of Patients (Pts) With Refractory or Relapsed and Refractory Multiple Myeloma (RRMM) and Renal Impairment (RI) Treated With Pomalidomide (POM) + Low-Dose Dexamethasone (LoDEX) in the Phase 3b STRATUS(TM) Trial (MM-010) (2015) (0)
Myocardial involvement in patients with Systemic Amiloidosis (2016) (0)
P-078: Prognostic value of immune cells in the multiple myeloma bone marrow microenvironment: a meta-analysis within silico and in vitro validation (2021) (0)
Involvement of NOTCH Signaling in Multiple Myeloma Angiogenesis and Progression (2015) (0)
Identification of EpHA3 As a New Potential Molecular Target in Multiple Myeloma. (2012) (0)
Junctional adhesion molecule-A as a prognostic factor and new therapeutic target in multiple myeloma. (2018) (0)
Vasculitis in Connective Tissue Diseases (2016) (0)
P317 FATAL EVOLUTION IN A YOUNG WOMAN DUE TO AMYLOIDOSIS HEART FAILURE IN A RARE MULTIPLE MYELOMA DISEASE (2022) (0)
The “angiogenic switch” from MGUS to MM: what about the Notch role? (2016) (0)
Circulating and bone marrow immunoglobulin-secreting cells in patients with monoclonal gammopathies. A simple and reliable marker for a B-cell function. (1985) (0)
Contents, Vol. 34, 1997 (1997) (0)
Mucine-1 Is Related to Cell-Mediated Immunoexpression and Blood Pressure in Pulmonary Artery in Pulmonary Arterial Hypertension (PAH): Preliminary Results. (2018) (0)
The Multiple Myeloma Bone Marrow Microenvironment (2012) (0)
Chronic inflammation enhances NGF-β/TrkA system expression via EGFR/MEK/ERK pathway activation in Sjögren’s syndrome (2014) (0)
Lymph node angiogenesis in lymphoproliferative disorders: type II Mixed cryoglobulinemia as a model. (1995) (0)
Real-life experience with omalizumab in chronic spontaneous urticaria. (2015) (0)
P-061: Single-cell whole-exome DNA sequencing traces clonal trajectory in paired evolution of MGUS to multiple myeloma (2021) (0)
Human Cancer Biology Gene Expression Profiling of Bone Marrow Endothelial Cells in Patients with Multiple Myeloma (2009) (0)
Early and Late Response and Glucocorticoid-Sparing Effect of Belimumab in Patients with Systemic Lupus Erythematosus with Joint and Skin Manifestations: Results from the Belimumab in Real Life Setting Study—Joint and Skin (BeRLiSS-JS) (2023) (0)
Is soybean patch testing a valid diagnostic tool for adult atopic dermatitis? A comparison of two methods. (2011) (0)
microRNAs as Biomarkers of Endothelial Dysfunction and Therapeutic Target in the Pathogenesis of Atrial Fibrillation (2023) (0)
Application of average volume assured pressure support (AVAPS) and ultrasound assessment in COVID-19 infection: real-life observation (0)
Emerging Concepts in Acute Heart Failure: From the Pathophysiology to the Clinical Case Based Approach (2017) (0)
The role of uric acid and HDL in vascular damage in hypertensive patients with well-contyrolled blood pressure. (2016) (0)
chronic lymphocytic leukemia Prognostic value of enhanced bone marrow angiogenesis in early B-cell (2013) (0)
OPTH_A_243203 775..793 (2020) (0)
Flogosis and heart involvement in large vessel vasculitis (2017) (0)
Case series on amyloidosis and organ involvement: a single center experience (2014) (0)
[Immunologic aspects of bronchopulmonary carcinoma]. (1991) (0)
Myelodysplastic Syndromes in the Elderly — A Prominent Medical Concern with Significant Effects on Healthcare Systems (2010) (0)
Vaccine based immunotherapy as a strategy to bypass drug resistance in multiple myeloma (2015) (0)
New aspects of myeloma management (2005) (0)
Cryptpogenic stroke: the complex interplay between endothelial dysfunction and interatrial defects orchestred by MTHFR mutation (2017) (0)
The Human Capacity Building and the Environmental Sustainability in Higher Education Green University: University of Bari as an Example (2015) (0)
Inhibition of Notch mediated communication in endothelial and plasma cells reduces angiogenesis in multiple myeloma patients. (2016) (0)
Subcutaneous Immunoglobulin for Treatment of Secondary Hypogammaglobulinemia in Multiple Myeloma (2015) (0)
STAT1 overexpression triggers aplastic anemia: a pilot study unravelling novel pathogenetic insights in bone marrow failure. (2023) (0)
Inhibition of Notch-mediated crosstalk between endothelial cells and plasmacells reduces angiogenesis in multiple myeloma patients. (2017) (0)
PATCH TESTING REACTIONS TO A STANDARD SERIES IN AN ITALIAN GENERAL HOSPITAL (2007) (0)
Role of HDL and uric acid in vascular damage in well controlled (2017) (0)
Antiangiogenic drugs as chemosensitizers in hematological tumors (2022) (0)
[Stimulation of B-cell immunity in the nude mice by pidotimod: immunohistochemical stucy of various lymphoid organs]. (1993) (0)
Contents Vol. 106, 2001 (2002) (0)
Subject Index Vol. 106, 2001 (2002) (0)
38 ANTIANGIOGENIC PROPERTIES OF IMMUNOMODULATORY DRUG LENALIDOMIDE IN ENDOTHELIAL CELLS OF PATIENTS WITH ACTIVE MULTIPLE MYELOMA (2010) (0)
Alessandro Moretta (1953-2018): The scientist, the man, the friend. (2018) (0)
New insights in Diffuse Large B Cell Lymphoma Pathobiology (2020) (0)
Efficacy of filgrastim, lenograstim and peg-filgrastim in the mobilization of peripheral blood progenitor cells in patients with lymphoproliferative disorders. (2014) (0)
Improving knowledge on the activation of bone marrow fibroblasts in MGUS and MM disease through the automatic extraction of genes via a nonnegative matrix factorization approach on gene expression profiles (2018) (0)
Abstracts of the 1 st Joint National Vascular Meeting of The British Microcirculation Society The British Society for Cardiovascular Research The Royal Society of Medicine Forum on Angiology (1996) (0)
“Exosomes-Mediate Crosstalk in Multiple Myeloma progression and drug Resistance” (2017) (0)
Amicrobial pustulosis or erosive pustular dermatosis of the inguinal folds: broad of the same spectrum? (2019) (0)
Title: Right Heart changes impact on clinical phenotype of amyloid cardiac involvement: a single centre study (2020) (0)
Identification of Novel Angiogenic Proteins in Multiple Myeloma Patient-Derived Endothelial Cells Using Proteome-Wide Analysis. (2009) (0)
Correction: Resveratrol Exerts Antiproliferative Activity and Induces Apoptosis in Waldenström Macroglobulinemia (2019) (0)
Sonography of superficial lymph nodes in malignant lymphomas. Data from our case series. (2015) (0)
Ion Channels in Multiple Myeloma: Pathogenic Role and Therapeutic Perspectives (2022) (0)
Correlation between vascular damage and metabolic parameters in hypertensives with well-controlled blood pressure: the role of uric acid and HDL. (2016) (0)
Bone marrow dendritic cells induce myeloma cell resistance to CD8+ T cell-mediated killing (2014) (0)
A SYNDROME CHARACTERIZED BY PSYCHIATRIC DISORDERS, RECURRENT MUCOSAL INFECTIONS AND NATURAL IMMUNITY DEFICITS: CLINICAL APPROACH (2001) (0)
Correlations between severity of obstructive sleep apnoea and systolic pulmonary artery pressure: preliminary results (2018) (0)
Contents, Vol. 99, 1992 (1992) (0)
Anti-Angiogenic Activity of Drugs in Multiple Myeloma (2023) (0)
Angiogenesis Associated with Alterations of the Bone Marrow Microenvironment Predicts Multiple Myeloma Progression to Symptomatic Disease in Mice and Humans (2014) (0)
Antiangiogenic activity of zoledronic acid: inhibition of the VEGF-VEGFR-2 autocrine loop in the endothelial cells of patients with multiple myeloma (2009) (0)
1 High-Risk Multiple Myeloma : Integrated Clinical 2 and Omics Approach Dissects the Neoplastic Clone 3 and the Tumor Microenvironment 4 (2019) (0)
Antibiotic treatment in vasculitic leg ulcers: a single center experience (2016) (0)
State-of-the-Art Review Endothelial Cell Heterogeneity and Organ Specificity (2002) (0)
07 Serum tryptase as a new biomarker in colorectal cancer patients (2012) (0)
Role of stromal cells in neovascularization of multiple myeloma (2009) (0)
Novel agents for multiple myeloma treatment. (2006) (0)
Purification and characterization of two novel Hemiscorpius lepturus scorpion venom-derived phospholipases A2 which inhibit angiogenesis in vitro (2016) (0)
Serum tryptase evaluation in HCC patients who underwent transarterial chemoembolization. (2011) (0)
Dyspnea, Fatigue, and Generalized Weakness in a 67-Year-Old Man:Approach to the Patient Between Guidelines and Clinical Judgment (2016) (0)
“miRNAs profile of bone marrow fibroblasts in multiple myeloma: relationship with disease progression and drug-resistance” (2017) (0)
Contents Vol. 29, 2010 (2010) (0)
Free laminin in the extracellular matrix of B-cell non Hodgkin's lymphomas. (1998) (0)
Subject Index, Vol. 34, 1997 (1997) (0)
Savage therapy with rituximab in severe lupus nephritis. (2015) (0)
Geospatial applications of the Internet of Things (IoT) : special issue (2018) (0)
Editorial [Hot Topic: Novel Agents for Multiple Myeloma Treatment (Guest Editors: D. Ribatti and A. Vacca)] (2006) (0)
Interplay between bone marrow endothelial cells and CD8 T cells in multiple myeloma. (2016) (0)
Proangiogenic effect of bone marrow fibroblasts in patients with multiple myeloma (2013) (0)
Angiogenesis and Antiangiogenesis in Multiple Myeloma Angiogenesis and Antiangiogenesis in Multiple Myeloma (2019) (0)
OAB-041: Epithelial-mesenchymal-transition regulated by Junctional Adhesion Molecule-A (JAM-A) associates with aggressive extramedullary multiple myeloma disease (2021) (0)
Relationship between echocardiographic assessment and plasma endothelin-1 levels in obese patients with or without obstructive sleep apnea (2015) (0)
Potential Role of MTHFR mutation in the interdipendence between interatrial defects and thrombophilia (2016) (0)
Rituximab induces a reduction of lymphocyte CD3+ activated in patients with autoimmune diseases (2017) (0)
Soluble CX3CL1/Fractalkine Is a New Player in the Pro-Inflammatory Microenvironment of Multiple Myeloma Patients Related to Bone Marrow Plasma Cell Infiltration and Neo-Vascularization (2017) (0)
[Immunoenzyme technics in immunohistochemistry. Immunoperoxidase and alkaline immunophosphatase]. (1988) (0)
Angiogenesis in unknown primary tumors (2012) (0)
P.17.12 Is Serum Tryptase Level in Colorectal Cancer Patients a Possible Novel Biomarker of Disease (2012) (0)
CD8 T cell regulation by bone marrow endothelial cells in multiple myeloma. (2016) (0)
Bone marrow fibroblasts provide a permissive microenvironment for multiple myeloma cells. (2010) (0)
Genes and proteins of myeloma endothelial cells to search specific targets of the tumor vasculature (2009) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Angelo Vacca?

Angelo Vacca is affiliated with the following schools:

Angelo Vacca's Academic­Influence.com Rankings

Angelo Vacca's Degrees

Similar Degrees You Can Earn

Why Is Angelo Vacca Influential?

Angelo Vacca's Published Works

Published Works

What Schools Are Affiliated With Angelo Vacca?

Angelo Vacca's AcademicInfluence.com Rankings